@article{SchrammFrauneNaumannetal.2011,
  author    = {Schramm, Sabine and Fraune, Johanna and Naumann, Ronald and Hernandez-Hernandez, Abrahan and H{\"o}{\"o}g, Christer and Cooke, Howard J. and Alsheimer, Manfred and Benavente, Ricardo},
  title     = {A Novel Mouse Synaptonemal Complex Protein Is Essential for Loading of Central Element Proteins, Recombination, and Fertility},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-68895},
  year      = {2011},
  abstract  = {The synaptonemal complex (SC) is a proteinaceous, meiosis-specific structure that is highly conserved in evolution. During meiosis, the SC mediates synapsis of homologous chromosomes. It is essential for proper recombination and segregation of homologous chromosomes, and therefore for genome haploidization. Mutations in human SC genes can cause infertility. In order to gain a better understanding of the process of SC assembly in a model system that would be relevant for humans, we are investigating meiosis in mice. Here, we report on a newly identified component of the murine SC, which we named SYCE3. SYCE3 is strongly conserved among mammals and localizes to the central element (CE) of the SC. By generating a Syce3 knockout mouse, we found that SYCE3 is required for fertility in both sexes. Loss of SYCE3 blocks synapsis initiation and results in meiotic arrest. In the absence of SYCE3, initiation of meiotic recombination appears to be normal, but its progression is severely impaired resulting in complete absence of MLH1 foci, which are presumed markers of crossovers in wild-type meiocytes. In the process of SC assembly, SYCE3 is required downstream of transverse filament protein SYCP1, but upstream of the other previously described CE-specific proteins. We conclude that SYCE3 enables chromosome loading of the other CE-specific proteins, which in turn would promote synapsis between homologous chromosomes.},
  subject      = {Maus},
  language  = {en}
}
@phdthesis{Goeb2011,
  author    = {G{\"o}b, Eva},
  title     = {Die Kernh{\"u}lle in Keimzellen: Strukturelle Besonderheiten, dynamische Prozesse und die Umgestaltung des Zellkerns w{\"a}hrend der Spermatogenese der Maus},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-56839},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2011},
  abstract  = {Die Kernh{\"u}lle umgibt als geschlossenes Membransystem einen jeden Zellkern und ist damit ein gemeinsames Merkmal aller eukaryotischen Zellen. Sie besteht aus einer inneren und einer {\"a}ußeren Kernmembran sowie der nukleoplasmatischen Kernlamina, die aufgrund zahlreicher assoziierter Proteine in enger Wechselbeziehung mit der inneren Kernmembran steht. Neben der rein r{\"a}umlichen Trennung nukle{\"a}rer und zytoplasmatischer Strukturen hat die Kernh{\"u}lle bedeutenden regulatorischen Einfluss auf die gesamte Zelle. So ist sie unter anderem an der Steuerung der genomischen Aktivit{\"a}t, an der nukleo- und zytoplasmatischen Signal{\"u}bertragung und in hohem Maße an der Positionierung und Formerhaltung des Zellkerns beteiligt. Es mehren sich die Hinweise, dass die Kernh{\"u}lle auch w{\"a}hrend der Gametogenese, der Differenzierung befruchtungsf{\"a}higer Keimzellen, eine zentrale Rolle einnimmt und folglich auch mit bislang ungekl{\"a}rten Ursachen humaner Infertilit{\"a}t in Kontext stehen k{\"o}nnte. Um die Bedeutung der Kernh{\"u}lle f{\"u}r die Keimbahn der S{\"a}uger generell besser verstehen zu k{\"o}nnen, wurden in dieser Arbeit ausgew{\"a}hlte Bestandteile der Keimzellkernh{\"u}lle untersucht. Dadurch sollte der Kenntnisstand erweitert werden, in welcher Weise die Kernh{\"u}lle dynamische, morphologische und vor allem f{\"u}r die Keimbahn essentielle Prozesse beeinflusst; insbesondere w{\"a}hrend der meiotischen und der postmeiotischen Differenzierungsphase bei m{\"a}nnlichen M{\"a}usen. Im Mittelpunkt stand dabei einerseits Lamin C2, ein meiosespezifisches A-Typ Lamin, dessen Verlust zu einer schwer gesch{\"a}digten Meiose und infolgedessen zu vollst{\"a}ndiger m{\"a}nnlicher Infertilit{\"a}t f{\"u}hrt. Es zeigte sich, dass Lamin C2-defiziente m{\"a}nnliche M{\"a}use schwerwiegende Defekte bei der Paarung und Synapsis der homologen Chromosomen in der meiotischen Prophase I aufweisen und aufgrund apoptotischer Spermatocyten keine reifen Spermien bilden k{\"o}nnen. Es wird angenommen, dass die Assoziation homologer Chromosomen bzw. die Abstoßung nicht-homologer durch gerichtete Telomerbewegungen entlang der Kernh{\"u}llenperipherie vorangetrieben bzw. verhindert wird. Da Lamin C2 seinerseits diese Wanderung der Telomere durch eine Flexibilisierung der Spermatocytenkernh{\"u}lle vereinfachen soll, ist es durchaus vorstellbar, dass sein Verlust verlangsamte Telomerbewegungen, eine gest{\"o}rte Homologenfindung und folglich Fehlpaarungen zur Folge hat. Ein weiteres zentrales Thema war die Erforschung potentieller LINC-Komplexe w{\"a}hrend der Differenzierungs- und morphologischen Umgestaltungsphase postmeiotischer Keimzellen. LINC-Komplexe sind kernh{\"u}llendurchspannende Proteingebilde aus SUN-Proteinen in der inneren und Nesprinen in der {\"a}ußeren Kernmembran, die nukle{\"a}re Strukturen an das Zytoskelett binden. Da sie aufgrund dieser strukturellen Eigenschaft die Kernmorphologie beeinflussen k{\"o}nnen, erscheinen sie als {\"a}ußerst geeignet, an der Formierung des Spermienkopfes beteiligt zu sein. Die detaillierte Untersuchung spermiogeneserelevanter LINC-Komplex-Bestandteile ergab, dass w{\"a}hrend der Spermiogenese tats{\"a}chlich zwei neue, strukturell einzigartige LINC-Komplexe gebildet werden, die dar{\"u}ber hinaus auf den entgegengesetzten Seiten differenzierender Spermatiden polarisieren. Da sie den Kern dort an jeweils spezielle Zytoskelettelemente binden k{\"o}nnten, wurde in dieser Arbeit das Modell der LINC-Komplex vermittelten Umformung des Spermienkopfes aufgestellt. Insgesamt tr{\"a}gt diese Arbeit durch die funktionelle Analyse von Lamin C2 und die Identifizierung neuer LINC-Komplexe dazu bei, die Wichtigkeit der Kernh{\"u}lle f{\"u}r die Spermatogenese zu vertiefen und auszuweiten.},
  subject      = {Spermatogenese},
  language  = {de}
}
@phdthesis{Duechs2011,
  author    = {D{\"u}chs, Matthias},
  title     = {Effects of Toll-like receptor agonists on the pathogenesis of atopic asthma in mice},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-66369},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2011},
  abstract  = {In the last decades, both the incidence and the severity of asthma have steadily increased. Furthermore, available therapies only treat the symptoms but do not cure the disease. Immune modulation induced by TLR agonists may be a promising novel approach to effectively treat asthma as it targets the underlying immunopathology directly rather than one mediator alone. The aim of this thesis was to investigate if the immunostimulatory properties of Toll-like receptor (TLR) agonists can be utilized to develop novel therapeutic intervention strategies for the treatment of asthma using murine models of allergic inflammation. For this purpose five different TLR agonists were tested in preclinical mouse models of acute and chronic asthma, both in preventive and therapeutic settings. Firstly, TLR-2, 3, 4, 7/8 and 9 agonists were delivered intratracheally at different doses before pulmonary allergen exposure in the asthma model of acute inflammation. TLR9 agonist CpG-containing oligodeoxynucleotides (CpG) > TLR7 agonist Resiquimod (R848) > TLR3 agonists poly(I:C) strongly reduced allergen induced airway eosinophilia and IL-4 levels in a dose-dependent manner. All TLR agonists increased neutrophil numbers, TLR4 agonist lipopolysaccharide (LPS) > TLR2 agonist lipoteichonic acid (LTA) > poly(I:C) > CpG > R848 and, with the exception of R848, the amount of pro-inflammatory cytokines in the airways. Suppressive effects were not dependent upon IFN-γ and IL-10 or associated with increased numbers of regulatory T cells in the airways. All TLR agonists, except LTA, similarly reduced airway eosinophilia and IL-4 levels when applied therapeutically after allergen challenge. These results show that the TLR agonists have different suppressive effects on TH2 responses in the airways which further depend on the dose and the experimental setup in which they were tested. Interestingly, all agonists induced airway neutrophilia, albeit to different degrees, raising the question if TLR ligands are safe for human use when applied directly into the lung. Different TLR agonists are also being developed for human use as adjuvants combined with allergen in specific immunotherapy. Recent clinical data suggest that this may be achieved by induction of allergen-specific TH1 responses. For this reason, the ability of different TLR agonists to induce allergen-specific TH1 and suppress allergen-specific TH2 responses in a preclinical setting was investigated in this thesis. Different doses of the TLR agonists were applied together with allergen, then mice were exposed to allergen aerosol. CpG > LPS >LTA dose-dependently strongly suppressed the development of airway eosinophilia with poly(I:C) and R848 having no effect. The decrease in eosinophilic numbers was associated withincreased neutrophils present in the airways. IL-4 and IL-5 levels in the bronchoalveolar lavage fluid were also decreased when poly(I:C), LPS, and CpG were used. All TLR agonists increased allergen-specific IgG2a, and with the exception of poly(I:C), reduced allergen-specific IgE levels in the serum. Cutaneous anaphylaxis to allergen was completely prevented when LPS or CpG were given as adjuvant. The strongest TH1 responses were induced by CpG and poly(I:C), characterized by the presence of IFN-γ in the bronchoalveolar lavage and the highest allergen-specific IgG2a levels in the serum. This data supports approaches to use TLR9 or TLR4 agonists for human therapy as adjuvant in combination with allergen in novel specific immunotherapy formulations. In the last part of the thesis, it was investigated if TLR activation can also affect the pathology of severe chronic asthma. Therapeutic administration of R848 or CpG reduced features of inflammation and remodeling. Both agonists showed superior effects to dexamethasone, with CpG being more efficient than R848. This result again supports a TLR9-based therapy as a viable option for the treatment of severe chronic asthma which may present a potential alternative for anti-inflammatory therapy with steroids. Taken together, the results of this thesis support the use of TLR agonists to treat asthma. The most favorable efficacy/safety ratio is to be expected from TLR-based therapies combining TLR4 or TLR9 agonists with allergen in specific immunotherapy. In regard to TLR agonist monotherapy, R848 and CpG showed the most promising profiles, CpG particularly in a model of severe chronic asthma. However, since all TLR agonists used in this study also showed pro-inflammatory potential, the safety aspect of such an approach needs to be taken into account.},
  subject      = {Toll-like Rezeptor},
  language  = {en}
}